Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VSAR

Versartis (VSAR) Stock Price, News & Analysis

Versartis logo

About Versartis Stock (NASDAQ:VSAR)

Advanced Chart

Key Stats

Today's Range
$1.18
$1.30
50-Day Range
$1.19
$1.19
52-Week Range
$1.14
$2.76
Volume
349,963 shs
Average Volume
479,436 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VSAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Versartis and its competitors with MarketBeat's FREE daily newsletter.

VSAR Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel
See More Headlines

VSAR Stock Analysis - Frequently Asked Questions

Versartis, Inc. (NASDAQ:VSAR) released its earnings results on Tuesday, August, 7th. The biopharmaceutical company reported ($0.27) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.96) by $0.69.

Based on aggregate information from My MarketBeat watchlists, some other companies that Versartis investors own include Progenics Pharmaceuticals (PGNX), ZIOPHARM Oncology (ZIOP), Bausch Health Cos (BHC), Flexion Therapeutics (FLXN), Genocea Biosciences (GNCA), Novavax (NVAX) and Protalix BioTherapeutics (PLX).

Company Calendar

Last Earnings
8/07/2018
Today
8/22/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:VSAR
CIK
1513818
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:VSAR) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners